KRYS - Krystal Biotech
This page shows which of the focused investors we track hold KRYS and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2025 it was held by 1 manager with an aggregate reported value of $2.95M, which is 0.00% of the combined portfolio.
As of Q4 2025, 1 tracked institutional manager held KRYS (Krystal Biotech) with an aggregate reported value of $2.95M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades KRYS — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2025
- Ticker
- KRYS
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Torray Funds - Torray Funds | 0.42% | Add +0.7% | 11,985 | $2.95M |
Loading holder history for KRYS…